A Phase III Study of Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents Aged Between 7 and 17 Years with Autism Spectrum Disorder (SIGN 1 Trial): Participant Baseline Characteristics
Georgoula, Christina, Ferrin, Maite, Pietraszczyk-Kedziora, Bozena, Hervas, Amaia, Marret, Stéphane, Oliveira, Guiomar, Rosier, Antoine, Crutel, Véronique, Besse, Emmanuelle, Severo, Cristina Albarrán, Ravel, Denis, Fuentes, Joaquin
Published in Child psychiatry and human development (01.10.2023)
Published in Child psychiatry and human development (01.10.2023)
Get full text
Journal Article
A phase 1/2, open‐label, dose‐escalation study of midostaurin in children with relapsed or refractory acute leukaemia
Zwaan, C. Michel, Söderhäll, Stefan, Brethon, Benoit, Luciani, Matteo, Rizzari, Carmelo, Stam, Ronald W., Besse, Emmanuelle, Dutreix, Catherine, Fagioli, Franca, Ho, Phoenix A., Dufour, Carlo, Pieters, Rob
Published in British journal of haematology (01.05.2019)
Published in British journal of haematology (01.05.2019)
Get full text
Journal Article
A Phase 1/2, Open-Label, Dose-Escalation Study of Midostaurin in Pediatric Patients (Pts) with Relapsed or Refractory (R/R) Acute Leukemia: Final Results of Study ITCC-024 (CPKC412A2114)
Zwaan, C. Michel, Söderhäll, Stefan, Brethon, Benoit, Luciani, Matteo, Rizzari, Carmelo, Sternberg, David, Besse, Emmanuelle, Dutreix, Catherine, Fagioli, Franca, Ho, Phoenix, Dufour, Carlo, Pieters, Rob
Published in BLOOD (03.12.2015)
Published in BLOOD (03.12.2015)
Get full text
Journal Article
Conference Proceeding